TY  - GEN
AU  - Goodkin,D E
AU  - Rudick,R A
AU  - VanderBrug Medendorp,S
AU  - Greene,T
AU  - Schwetz,K M
AU  - Fischer,J
AU  - Daughtry,M M
AU  - Ross,J
AU  - Van Dyke,C
TI  - Low-dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicity
SN  - 1059-2725
PY  - 1994///0317
KW  - Adult
KW  - Central Nervous System
KW  - drug effects
KW  - Chronic Disease
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Male
KW  - Methotrexate
KW  - administration & dosage
KW  - Middle Aged
KW  - Multiple Sclerosis
KW  - drug therapy
KW  - Neuropsychological Tests
KW  - Outcome Assessment, Health Care
KW  - Research Design
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
ER  -